2022 AIM Leadership in Action Conference
These presentations and accompanying resources were presented at the 2022 AIM Leadership in Action Conference. For any questions or additional information, please contact us.
Safety & Immunogenicity of a 3-Antigen Hepatitis B Vaccine, PreHevbrio [Hepatitis B Vaccine (Recombinant)] Webinar
AIM Policy Summary: April 29, 2022
AIM Legislative Round-Up: April 29, 2022
AIM State Legislative Round-Up
We continue to see a flurry of vaccine-related legislative activity, especially as many state legislatures rush to adjournment. While most of the AIM reporting has focused on anti-vaccine proposals, we wanted to use this round-up to highlight a small bright spot. Both California and the District of Columbia recently passed legislation that provides paid sick leave for certain covered employees for the time needed to attend vaccination appointments. Information on these bills is available here and here. Finally, as an addendum to the last video on working with coalitions, we wanted to highlight a new organization working to build momentum for pro-vaccine policy and policymakers. The SAFE Communities Coalition was recently formed with a mandate to advocate for pro-science legislation, elect pro-science candidates, and defeat anti-vaccination candidates. More information on their work can be found here.